The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.103
Bid: 0.098
Ask: 0.103
Change: 0.0015 (1.52%)
Spread: 0.005 (5.102%)
Open: 0.103
High: 0.103
Low: 0.103
Prev. Close: 0.099
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

10 Jan 2024 11:29

RNS Number : 2717Z
Versarien PLC
10 January 2024
 

10 January 2024

Versarien Plc

("Versarien" or the "Company")

Result of General Meeting

Versarien Plc (AIM: VRS), the advanced materials engineering group, is pleased to confirm that at the Company's General Meeting held earlier today, all resolutions were duly passed. Full details of the resolutions are set out in the Notice of General Meeting dated 20 December 2023 and available on the Company's website at: https://www.versarien.com/investors/reports-and-presentations/

The proxy votes cast were as follows:

Resolution

 

For

 

 

Against

 

 

Abstain

1 - to sub-divide each Existing

Ordinary Share into one New Ordinary Share and one New Deferred Share

 

22,939,297

93.25%

1,661,734

6.75%

303,606

2 - a special resolution to alter the Articles to allow for the issue of New Deferred Shares by including provisions relating to the rights and restrictions attached to the New Deferred Shares

 

22,992,555

93.78%

1,524,588

6.22%

387,494

3 - to grant the directors authority to allot up to 992,339,000 New Ordinary Shares

 

22,754,233

93.16%

1,670,424

6.84%

479,980

4 - a special resolution to grant the directors authority to allot up to 992,339,000 New Ordinary Shares for cash without first offering them to existing shareholders

 

22,530,861

92.30%

1,880,416

7.70%

493,360

 

Share Capital Reorganisation

Following the passing of the resolutions at the General Meeting, each of the Company's 496,169,507 Existing Ordinary Shares will be sub-divided into one New Ordinary Share of 0.01p (the "New Ordinary Shares") and one deferred share of 0.09p ("New Deferred Shares"). The New Deferred Shares will have little economic value as they will not carry any rights to vote or dividend rights, although the New Deferred Shares will rank pari passu with the New Ordinary Shares on a return of capital or on a winding up of the Company.

 

Admission to AIM and Total Voting Rights

Dealings on AIM in the Existing Ordinary Shares is expected to cease at the close of business on 10 January 2024. Application has been made for the admission of 496,169,507 New Ordinary Shares to trading on AIM ("Admission") and it is expected that Admission will take place and that trading in the New Ordinary Shares will commence at 8.00 a.m. on or around 11 January 2024. No application will be made for admission of the New Deferred Shares to trading on AIM nor will any such application be made to any other exchange.

Following Admission, there will be a total of 496,169,507 New Ordinary Shares, with voting rights, in issue. The Company does not hold any shares in treasury. Consequently, 496,169,507 is the figure which may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Unless otherwise indicated, all defined terms in this announcement shall have the same meaning as described in the Company's announcement dated 20 December 2023 and the Circular which was posted to shareholders on the same day.

For further information please contact:

 

Versarien

Stephen Hodge, Chief Executive Officer

Chris Leigh, Chief Financial Officer

 

c/o IFC

SP Angel Corporate Finance (Nominated Adviser and Broker)

Matthew Johnson, Adam Cowl

 

+44 (0)20 3470 0470

 

IFC Advisory Limited (Financial PR and Investor Relations)

Tim Metcalfe, Zach Cohen

+44 (0) 20 3934 6630

 

For further information please see: http://www.versarien.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMGPURPGUPCGGU
Date   Source Headline
1st Dec 20224:41 pmRNSSecond Price Monitoring Extn
1st Dec 20224:35 pmRNSPrice Monitoring Extension
2nd Nov 20224:35 pmRNSPrice Monitoring Extension
30th Sep 202212:48 pmRNSResult of AGM
28th Sep 20224:41 pmRNSSecond Price Monitoring Extn
28th Sep 20224:36 pmRNSPrice Monitoring Extension
26th Sep 20227:00 amRNSBiaBrazil to utilise Graphene-Wear Technology
24th Aug 20227:00 amRNSNotice of AGM
30th Jun 20227:00 amRNSVerified Graphene Producer Re-certification
27th Jun 20227:00 amRNSLaunch of New Superparamagnetic Material
12th May 20227:00 amRNSInterim Results
10th May 20227:00 amRNSUmbro to Utilise Versarien’s Graphene-Wear Tech
3rd May 20227:00 amRNSNotice of Results and Investor Presentation
25th Apr 20223:25 pmRNSHolding(s) in Company
9th Mar 20227:00 amRNSLaunch of Lunar 3D printed lifestyle pods
24th Feb 20227:00 amRNSChange of Auditors and Accounting Reference Date
22nd Feb 20227:00 amRNSFlux Footwear to launch graphene enhanced shoe
20th Jan 20227:00 amRNSInvestor Event
4th Jan 20227:00 amRNSConfirmation of Board Change
24th Dec 20217:00 amRNSHolding(s) in Company
10th Dec 20217:00 amRNSInvestor Presentation
6th Dec 20217:00 amRNSInterim Results
2nd Dec 20217:00 amRNSNotice of Results and Investor Presentation
17th Nov 20212:27 pmRNSHolding(s) in Company
16th Nov 202112:31 pmRNSSuperdry partners with Versarien
11th Nov 20217:00 amRNSInvestor Presentation
1st Nov 20217:00 amRNSConsortium wins Department for Transport backing
29th Oct 20211:41 pmRNSResponse to Media Speculation
29th Oct 20217:00 amRNSInvestor Presentation
13th Oct 20217:00 amRNSAppointment of Non-executive Chairman
23rd Sep 20212:08 pmRNSResult of AGM
2nd Sep 202111:01 amRNSChange of Registered Address
27th Aug 20211:54 pmRNSNotice of AGM and Posting of Annual Report
11th Aug 20219:53 amRNSHolding(s) in Company
5th Aug 20217:00 amRNSPreliminary Results
30th Apr 20217:00 amRNSTotal Voting Rights
9th Apr 20217:00 amRNS£1.93m strategic investment by Graphene Lab
26th Feb 202110:16 amRNSInnovate UK Loan
9th Feb 20217:00 amRNSGraphene Enhanced Mask Update
22nd Jan 202111:05 amRNSDirector/PDMR Shareholding
21st Jan 20217:00 amRNSInterim Results
7th Jan 20217:00 amRNSAppointment of Chief Technology Officer
31st Dec 20207:00 amRNSTotal Voting Rights
30th Dec 20207:00 amRNSHolding(s) in Company
23rd Dec 202012:31 pmRNSHolding(s) in Company
22nd Dec 20207:00 amRNSAcquisition, Subscription & Sharing Agreement
24th Nov 20207:00 amRNS£1.95 million Development Agreement
23rd Nov 20204:39 pmRNSInterim Results Reporting Extension
18th Nov 20207:00 amRNSSARS-CoV-2 Inhibition by Graphene / Metal Oxides
21st Oct 202012:00 pmRNSResult of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.